To identify the structural determinants necessary for opioid receptor desensitization, we serially ablated potential phosphorylation sites in the carboxyl tail of the receptor and examined their effects on [D-Ala 2 ,N-MePhe 4 ,Gly-ol 5 ]enkephalin (DAMGO)-induced desensitization. First, we replaced Thr 394 with alanine (T394A) and stably expressed this mutant receptor in Chinese hamster ovary cells. The T394A receptor did not desensitize after 1 h of treatment with DAMGO, indicating that Thr 394 is required for agonist-induced early desensitization. To test whether Thr 394 was the only residue necessary, we investigated the importance of 7 potential phosphorylation sites between residues 363 and 383, which were all replaced by alanines with the Thr 394 maintained. This mutant (AT) showed partial loss of desensitization (30%), which was attributable to the Ala mutation at Thr 383 , since complete desensitization was achieved by restoring Thr 383 (ATT). These results suggest that Thr 394 is the primary recognition site for G protein-coupled receptor kinases, but Thr 383 is also required for complete agonist-induced desensitization. The specificity of Thr 394 as the primary initiation site appears to be dependent on the preceding acidic amino acid stretch, because in a mutant in which glutamic acid residues at 388, 391, and 393 were replaced by glutamines (EQ), agonist-induced desensitization was completely abolished, identical to the T394A mutant.Desensitization is defined as loss of a biological response to a ligand despite its continuous presence. This phenomenon of desensitization is observed with almost every receptor, and some of the mechanisms involved in desensitization of G protein-coupled receptors have been well characterized using the -adrenergic receptor (AR) 1 and rhodopsin. For these receptors, the primary mechanism of desensitization appears to be receptor phosphorylation mediated by G protein-coupled receptor kinases (GRKs). Since these kinases have the unique feature of phosphorylating receptors only when they are in an active or a ligand-bound conformation, GRK-mediated phosphorylation is considered to be the main mechanism for agonist-induced desensitization. These kinases have been shown to phosphorylate a number of G protein-coupled receptors including the AR (1, 2), rhodopsin (3, 4), ␣ 2 -adrenergic receptor (␣ 2 AR) (5, 6), platelet-activating factor receptor (7), thrombin receptor (8), and C5a anaphylatoxin receptor (9).Endogenous opioids play an important role in a variety of physiological processes through pharmacologically distinct, three major receptor subtypes that are coupled to inhibitory G proteins (10). Although the acute action of opioids can induce a number of beneficial effects, chronic use of opioids produces tolerance and dependence (11, 12), which are among the major factors limiting the clinical use of opioids. The molecular mechanisms underlying these phenomena are poorly understood, and receptor desensitization has been implicated as a possible mechanism.It has been sho...